How many insider declarations has Anders Liljeblad filed?

Anders Liljeblad has filed 3 public insider declarations with FIN-FSA.

What is Anders Liljeblad's role?

Anders Liljeblad's reported role is not specified by the regulator across the filings.

Which companies does Anders Liljeblad report trades for?

Anders Liljeblad reports trades for Prostatype Genomics AB.

← Executives ★ Sign in to follow

AL

Anders Liljeblad

·FIN-FSA

Prostatype Genomics AB

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Browse the complete record of transactions filed by Anders Liljeblad. Officer active across 1 company, notably Prostatype Genomics AB. Cumulatively, 3 disclosures have been logged. Activity tracked since 31 August 2026. The latest transaction was filed on 31 August 2026 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.

Companies and markets linked to Anders Liljeblad

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Prostatype Genomics AB (FI)

Declarations3 total

●

Anders Liljeblad

Verkställande direktör (VD)Executives31 Aug 2026Prostatype Genomics AB

SEK 575,0000FI-SE ↗

5,750,000 shares@ SEK 0.10AktieSE0023261532FI:csv-78ed7f85ce46a6e56bfe

●

Anders Liljeblad

Verkställande direktör (VD)Executives31 Aug 2026Prostatype Genomics AB

0FI-SE ↗

1,437,500 shares0TeckningsoptionSE0029529767FI:csv-4d1e1875c74cc399188b

●

Anders Liljeblad

Verkställande direktör (VD)Executives31 Aug 2026Prostatype Genomics AB

0FI-SE ↗

2,875,000 shares0TeckningsoptionSE0029529783FI:csv-735015975c41aeefc715

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

AL

Anders Liljeblad

·FIN-FSA

Prostatype Genomics AB

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Browse the complete record of transactions filed by Anders Liljeblad. Officer active across 1 company, notably Prostatype Genomics AB. Cumulatively, 3 disclosures have been logged. Activity tracked since 31 August 2026. The latest transaction was filed on 31 August 2026 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.